| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/19/2006 | CA2573505A1 N-glycosylated antibody |
| 01/19/2006 | CA2572881A1 Antigen binding proteins directed against scavenger receptor b1 that inhibit hcv replication |
| 01/19/2006 | CA2544692A1 Anti-glypican 3 antibody |
| 01/18/2006 | EP1616958A2 Notch-ligands for use in immunotherapy |
| 01/18/2006 | EP1616942A2 Patched genes and their use |
| 01/18/2006 | EP1616885A1 Recombinant antibody recognizing dioxin and gene encoding the antibody |
| 01/18/2006 | EP1616884A2 Zcytor7 cytokine receptor and antibody thereto |
| 01/18/2006 | EP1616883A2 Antibodies against VLA-4 |
| 01/18/2006 | EP1616882A2 Apo-2 receptor antibodies |
| 01/18/2006 | EP1616881A1 Anti-mpl antibodies |
| 01/18/2006 | EP1616880A1 Ligand having agonistic activity to mutated receptor |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616876A2 A method for identification, isolation and production of antigens to a specific pathogen |
| 01/18/2006 | EP1616579A1 CD40 binding molecules and CTL peptides for treating tumors |
| 01/18/2006 | EP1616575A1 Method for treating inflammation |
| 01/18/2006 | EP1616572A1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody |
| 01/18/2006 | EP1616190A1 Diagnosis of advanced cancer |
| 01/18/2006 | EP1616024A1 The use of pde4d in the screening for medicaments against atherosclerosis |
| 01/18/2006 | EP1616020A2 Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon |
| 01/18/2006 | EP1616010A2 Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylphosphatidylinositol |
| 01/18/2006 | EP1615996A2 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip) |
| 01/18/2006 | EP1615956A1 Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations |
| 01/18/2006 | EP1615955A2 Alteration of fcrn binding affinities or serum half-lives of antibodies by mutagenesis |
| 01/18/2006 | EP1615952A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 01/18/2006 | EP1615946A2 Proteolytic and covalent antibodies |
| 01/18/2006 | EP1615670A2 Targets for tumor growth inhibition |
| 01/18/2006 | EP1615664A1 Pharmaceutical composition for treatment of immunological disorders |
| 01/18/2006 | EP1615654A2 Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques |
| 01/18/2006 | EP1373547A4 Control of glycoforms in igg |
| 01/18/2006 | EP1278851B1 Humanised antibodies to the epidermal growth factor receptor |
| 01/18/2006 | EP1071442B9 Methods and compositions for peptide synthesis (t-20) |
| 01/18/2006 | EP0815197B1 Long qt genes and method for diagnosing or preventing the occurrence of long qt syndrome |
| 01/18/2006 | EP0782630B1 Polycystic kidney disease gene |
| 01/18/2006 | EP0735895B1 A method for preventing or controlling cataract |
| 01/18/2006 | CN1723391A Oligopeptides for promoting hair growth |
| 01/18/2006 | CN1723283A Method for manufacturing recombinant polyclonal proteins |
| 01/18/2006 | CN1723220A A pharmaceutical composition comprising an immunoglobulin FC region as a carrier |
| 01/18/2006 | CN1723219A Protein complex using immunoglobulin fragment andmethod for the preparation thereof |
| 01/18/2006 | CN1723042A Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 01/18/2006 | CN1723039A Methods for treating post-surgical pain by admisnistering a nerve growth factor antagonist and compositions containing the same |
| 01/18/2006 | CN1723032A Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 01/18/2006 | CN1722953A Methods for treating cancer by inhibiting Wnt signaling |
| 01/18/2006 | CN1721553A Methods for assessing and treating cancer |
| 01/18/2006 | CN1721535A Human secreted protein hZG16 |
| 01/18/2006 | CN1721534A Human secreted protein hPAP21 |
| 01/18/2006 | CN1721528A Novel human complement C1r-like serine proteinase analogue, and its encoding sequence and use |
| 01/18/2006 | CN1721447A Modified peptides as therapeutic agents |
| 01/18/2006 | CN1721445A Degraded TPO agonist antibody |
| 01/18/2006 | CN1721444A Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 01/18/2006 | CN1721443A Human receptor proteins, related reagents and methods |
| 01/18/2006 | CN1721438A Human secreted protein hCGI-143 |
| 01/18/2006 | CN1721437A Polypeptide antigen and antibody related to Tau protein |
| 01/18/2006 | CN1721434A Novel protein, genes encoding the same and method of using the same |
| 01/18/2006 | CN1720991A Degraded agonist antibody |
| 01/18/2006 | CN1237175C Protein production in transgenic alfalfa plants |
| 01/18/2006 | CN1237173C Hemolytic peptide precursor gene of Asian-African wasp aptoxin, polypeptide coded by it and its preparing process |
| 01/18/2006 | CN1237172C Asia-africa hornet sedative peptide precursor gene and its coded polypeptide and preparing method |
| 01/18/2006 | CN1237076C Polypeptide variants with altered effector function |
| 01/18/2006 | CN1236818C Caprine arthritis-encephalitis virus provided immunoprotection against HIV-1 infection |
| 01/18/2006 | CN1236815C Application of integrin antagonists in preparation of medicine for treating multiple myeloma and myeloma-induced bone resorption |
| 01/17/2006 | US6987171 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
| 01/17/2006 | US6987169 Nucleotide sequences coding polypeptide for use in the treatment of cancer, heart and viral diseases |
| 01/17/2006 | US6987167 Process for production of the somatostatin analog, octreotide |
| 01/17/2006 | US6987166 Anti-C5a antibodies |
| 01/17/2006 | US6987088 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 01/17/2006 | US6987014 Isolated nucleic acid molecules encoding human drug metabolizing proteins |
| 01/17/2006 | US6987006 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | US6987001 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 01/17/2006 | US6986996 Using anti-heparanase antibody to bind heparanase encoded by amino acid sequence no.1 for monitoring heparanase protein expression of heparanase gene in white blood cells in vitro; drug delivery targets; diagnosis of tumors, cancer and metastasis |
| 01/17/2006 | US6986986 subcloning nucleic acids encoding displayed polypeptides of enriched libraries from a display vector to an expression vector without the need for clonal isolation of individual members |
| 01/17/2006 | US6986891 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| 01/17/2006 | US6986890 Anti-human VEGF receptor Flt-1 monoclonal antibody |
| 01/17/2006 | US6986889 Complexing; removal from blood circulation |
| 01/17/2006 | CA2374882C Molecular characterisation of chromosome translocation t(11;18)(q21;q21) and its correlation to carcinogenesis |
| 01/17/2006 | CA2271544C Method to detect bone and other connective tissue disorders in humans and animals |
| 01/12/2006 | WO2006004950A2 Humanized monoclonal antibody 31.1 as an anticancer agent |
| 01/12/2006 | WO2006004663A2 Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis |
| 01/12/2006 | WO2006004549A1 ACETYL CoA CARBOXYLASE SPLICE VARIANT AND USES THEREOF |
| 01/12/2006 | WO2006003518A2 6-phosphorylcholine-n-acetyl-d-galactosamine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications against bacterial infection of the respiratory tract |
| 01/12/2006 | WO2006003426A1 Treatment of bacterial infections |
| 01/12/2006 | WO2006003407A2 Chimeric and humanised monoclonal antibodies against inteleukin- 13 |
| 01/12/2006 | WO2006003388A2 Compositions and methods for treating inflammatory disorders |
| 01/12/2006 | WO2006003384A1 Treatment of cancer |
| 01/12/2006 | WO2006003179A2 Antibodies binding to receptors kir2dl1, -2, 3 but not kir2ds4 and their therapeutic use |
| 01/12/2006 | WO2006002774A1 Novel monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding their variable regions, and their uses in diagnostic, preventive and therapeutic medicine |
| 01/12/2006 | WO2005111080A3 Methods for reducing biofilm formation in infectious bacteria |
| 01/12/2006 | WO2005110472A8 Agent for actively restoring structure and functions of damaged tissues and organs |
| 01/12/2006 | WO2005094883A3 Methods for inducing autolysis in infectious bacteria |
| 01/12/2006 | WO2005094879A3 Monoclonal antibodies specific for human ox40l (cd 134l) |
| 01/12/2006 | WO2005090573A3 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 01/12/2006 | WO2005079479A3 Super-humanized antibodies against respiratory syncytial virus |
| 01/12/2006 | WO2005049652A3 Methods of generating antibody diversity in vitro |
| 01/12/2006 | WO2005030123A3 Botulinum antitoxin compositions and methods |
| 01/12/2006 | WO2005027836A3 Immunogen |
| 01/12/2006 | WO2004031354A3 Human sarcoma-associated antigens |
| 01/12/2006 | US20060009631 Nucleic acids encoding this enzyme; in humans, rodents; isotopes; purity; gene expression; transformation, translation of cells; sulfation of tyrosine; hybridization |
| 01/12/2006 | US20060009630 Composition for treating squamous cell carcinoma comprising an antibody that specifically binds a migration facilitating protein comprising a laminin 5 alpha 3 G4 and/or 5 domain or subdomain thereof, and a pharmaceutically acceptable carrier; treatment of skin cancer |
| 01/12/2006 | US20060009622 inflammatory bowel disease, rheumatoid arthritis, acromegaly, tuberculosis, tumor of the lung, breast, brain, eye, prostate or colon, a tumor of neuroendocrine origin, an angiogenesis disease that causes inappropriate proliferation of blood vessels, retinal macular degeneration or diabetic neuropathy |
| 01/12/2006 | US20060009621 For detecting a PMS2 protein, including a truncated PMS2, for detecting a predisposition to cancer, monoclonal antibody |